Differential ability of cells to promote oxidation of low density lipoproteins in vitro
Data up to Jan 2025
Total Citations Per Year
Abstract
References (41)
The pathogenesis of atherosclerosis: a perspective for the 1990s
1993 • 10,730 citations
A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
1978 • 6,494 citations
Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.
1989 • 1,914 citations
Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids.
1984 • 1,631 citations
Low density lipoprotein undergoes oxidative modification in vivo.
1989 • 1,537 citations
Autoantibody against oxidised LDL and progression of carotid atherosclerosis
1992 • 1,332 citations
Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.
1987 • 1,152 citations
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells.
1990 • 1,147 citations
Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
1987 • 1,051 citations
Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.
1981 • 1,037 citations
Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
1987 • 885 citations
Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.
1988 • 655 citations
Lipoprotein oxidation and lipoprotein-induced cytotoxicity.
1983 • 545 citations
Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.
1986 • 516 citations
Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions
1992 • 463 citations
A role for endothelial cell lipoxygenase in the oxidative modification of low density lipoprotein.
1989 • 417 citations
Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor.
1986 • 417 citations
The Role of Oxidized Low-Density Lipoproteins in the Pathogenesis of Atherosclerosis
1992 • 386 citations
Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin.
1989 • 231 citations
Role of superoxide in endothelial-cell modification of low-density lipoproteins
1988 • 228 citations
Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis.
1991 • 183 citations
Role of endothelial cells and their products in the modification of low-density lipoproteins
1986 • 159 citations
Activated human monocytes oxidize low-density lipoprotein by a lipoxygenase-dependent pathway.
1990 • 132 citations
Cellular Mechanisms of Lipid Injury in the Glomerulus
1993 • 104 citations
Culture of human endothelial cells.
1980 • 102 citations
Oxidation of low density lipoprotein by mesangial cells may promote glomerular injury
1994 • 98 citations
Oxidized low-density lipoprotein in experimental focal glomerulosclerosis
1993 • 83 citations
The oxidative modification of low density lipoprotein by human lymphocytes
1992 • 74 citations
Oxidative modification of low-density lipoproteins by mesangial cells.
1993 • 72 citations
In vivo inhibition of foam cell development by probucol in Watanabe rabbits
1988 • 71 citations
Stable cell lines of T-SV40 immortalized human glomerular mesangial cells
1996 • 65 citations
Renal vasoconstriction caused by short-term cholesterol feeding is corrected by thromboxane antagonist or probucol.
1990 • 61 citations
Oxidized Low-Density Lipoprotein Stimulates Protein Kinase C (PKC) and Induces Expression of PKC-Isotypes via Prostaglandin-H-Synthase in P388D1Macrophage-Like Cells
1996 • 40 citations
Tubular lipidosis: Epiphenomenon or pathogenetic lesion in human renal disease?
1994 • 36 citations
Activation of 15-lipoxygenase by low density lipoprotein in vascular endothelial cells. Relationship to the oxidative modification of low density lipoprotein
1992 • 30 citations
Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages
1988 • 29 citations
Effects of dietary fatty acids in an animal model of focal glomerulosclerosis
1991 • 28 citations
Human (THP-1) Macrophages Oxidize LDL by a Thiol-Dependent Mechanism
1994 • 27 citations
Oxidation of low-density lipoproteins by rat mesangial cells and the interaction of oxidized low-density lipoproteins with rat mesangial cells in vitro
1993 • 26 citations
Effects of oxidized low density lipoproteins on arachidonic acid metabolism in smooth muscle cells.
1990 • 22 citations
Culture of Human Endothelial Cells
2003 • 3 citations